Drug intelligence / Profile preview

APA-01

Development stage
Preclinical
Lead developer
PharmAla Biotech
Modality
Small Molecules
01

Overview

APA-01 is a novel small molecule phenethylamine derivative developed by PharmAla Biotech. It is designed as a potent entactogen with an improved safety pharmacology profile compared to MDMA. Mechanistically, APA-01 acts as a 5-HT1A receptor agonist, a feature that distinguishes it from traditional MDMA and potentially expands its therapeutic applications. The compound is intended to promote the regrowth of neuronal connections in damaged brain regions, suggesting potential utility in treating neurological disorders such as traumatic brain injury (TBI) and stroke. Additionally, it is being explored for neuropsychiatric conditions, including fear disorders and psychological trauma. As of late 2024, APA-01 is in preclinical development, with animal research data highlighting its MDMA-like effects without the associated safety concerns of the parent compound.

Other names
(R)-2-[(2H-1,3-Benzodioxol-5-YL)Methyl]Pyrrolidine
02

Targets

HTR1A (Serotonin receptor 1A (5-hydroxytryptamine receptor 1A))

Beyond the preview

Go deeper on APA-01.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on APA-01.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call